Literature DB >> 21546797

HBc binds to the CpG islands of HBV cccDNA and promotes an epigenetic permissive state.

Yan-Hai Guo1, Yong-Nian Li, Jin-Rong Zhao, Ju Zhang, Zhen Yan.   

Abstract

HBV covalently closed circular DNA (cccDNA) is the template for the transcription of HBV. HBV core protein (HBc) is a main component of the HBV cccDNA minichromosome. However, the function of HBc in cccDNA is not fully understood. In light of recent findings that HBV cccDNA may be regulated epigenetically, we analyzed the binding of HBc to cccDNA and the impact of HBc on cccDNA epigenetic profile in the liver biopsy samples of 22 patients with chronic Hepatitis B (CHB). We found that HBc binding to HBV cccDNA occurred preferentially at CpG island 2, an important region for the regulation of HBV transcription. Furthermore, the relative abundances of HBc binding to CpG island 2 were positively correlated with the ratios of relaxed circular DNA to cccDNA and the levels of serum HBV DNA in those patients. Interestingly, the relative abundances of HBc binding to CpG island 2 were associated with the binding of CREB binding protein (CBP) and with hypomethylation in CpG island 2 of HBV cccDNA minichromosomes. However, relatively higher amounts of HBc binding to CpG island 2 of cccDNA were accompanied by lower amounts of HDAC1 binding. Multivariate analysis revealed that the abundances of HBc binding to CpG island 2 of cccDNA and positive HBeAg were independent factors associated with the replication of HBV (p = 0.001 for both). Apparently, HBc is a positive regulator of HBV transcription and replication, maintaining the permissive epigenetic state in the critical region of the HBV cccDNA minichromosomes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21546797     DOI: 10.4161/epi.6.6.15815

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  52 in total

Review 1.  Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics.

Authors:  Ju-Tao Guo; Haitao Guo
Journal:  Antiviral Res       Date:  2015-08-10       Impact factor: 5.970

Review 2.  The diverse functions of the hepatitis B core/capsid protein (HBc) in the viral life cycle: Implications for the development of HBc-targeting antivirals.

Authors:  Ahmed Diab; Adrien Foca; Fabien Zoulim; David Durantel; Ourania Andrisani
Journal:  Antiviral Res       Date:  2017-11-26       Impact factor: 5.970

Review 3.  The Structural Biology of Hepatitis B Virus: Form and Function.

Authors:  Balasubramanian Venkatakrishnan; Adam Zlotnick
Journal:  Annu Rev Virol       Date:  2016-08-01       Impact factor: 10.431

4.  Novel Hepatitis B Virus Capsid-Targeting Antiviral That Aggregates Core Particles and Inhibits Nuclear Entry of Viral Cores.

Authors:  Andrew D Huber; Dallas L Pineda; Dandan Liu; Kelsey N Boschert; Anna T Gres; Jennifer J Wolf; Emily M Coonrod; Jing Tang; Thomas G Laughlin; Qiongying Yang; Maritza N Puray-Chavez; Juan Ji; Kamalendra Singh; Karen A Kirby; Zhengqiang Wang; Stefan G Sarafianos
Journal:  ACS Infect Dis       Date:  2019-01-14       Impact factor: 5.084

5.  Mechanisms and Effects on HBV Replication of the Interaction between HBV Core Protein and Cellular Filamin B.

Authors:  Yilin Li; Yishuang Sun; Fuyun Sun; Rong Hua; Chenlin Li; Lang Chen; Deyin Guo; Jingfang Mu
Journal:  Virol Sin       Date:  2018-03-28       Impact factor: 4.327

6.  Core gene insertion in hepatitis B virus genotype G functions at both the encoded amino acid sequence and RNA structure levels to stimulate core protein expression.

Authors:  Jing Zhang; Li Zong; Yongxiang Wang; Cheng Li; Chaoyang Chen; Yumei Wen; Jisu Li; Shuping Tong
Journal:  Virology       Date:  2018-11-08       Impact factor: 3.616

Review 7.  The current status and future directions of hepatitis B antiviral drug discovery.

Authors:  Liudi Tang; Qiong Zhao; Shuo Wu; Junjun Cheng; Jinhong Chang; Ju-Tao Guo
Journal:  Expert Opin Drug Discov       Date:  2016-11-11       Impact factor: 6.098

Review 8.  Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential.

Authors:  Yuchen Xia; Haitao Guo
Journal:  Antiviral Res       Date:  2020-05-22       Impact factor: 5.970

Review 9.  Core protein: A pleiotropic keystone in the HBV lifecycle.

Authors:  Adam Zlotnick; Balasubramanian Venkatakrishnan; Zhenning Tan; Eric Lewellyn; William Turner; Samson Francis
Journal:  Antiviral Res       Date:  2015-06-27       Impact factor: 5.970

10.  Preclinical Profile of AB-423, an Inhibitor of Hepatitis B Virus Pregenomic RNA Encapsidation.

Authors:  Nagraj Mani; Andrew G Cole; Janet R Phelps; Andrzej Ardzinski; Kyle D Cobarrubias; Andrea Cuconati; Bruce D Dorsey; Ellen Evangelista; Kristi Fan; Fang Guo; Haitao Guo; Ju-Tao Guo; Troy O Harasym; Salam Kadhim; Steven G Kultgen; Amy C H Lee; Alice H L Li; Quanxin Long; Sara A Majeski; Richeng Mao; Kevin D McClintock; Stephen P Reid; Rene Rijnbrand; Nicholas M Snead; Holly M Micolochick Steuer; Kim Stever; Sunny Tang; Xiaohe Wang; Qiong Zhao; Michael J Sofia
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.